Scientists use nanoparticle-delivered gene therapy to
inhibit blinding eye disease in rodents

In experiments in rats and mice, two Johns Hopkins
scientists—an engineer and an ophthalmologist—report the successful
use of nanoparticles to deliver gene therapy for blinding eye
disease. A uniquely engineered large molecule allows researchers to
compact large bundles of therapeutic DNA to be delivered into the
cells of the eye.